Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Mainland China, Taiwan and Hong Kong

被引:0
|
作者
Pan, Changyu
Han, Ping
Ji, Qiuhe
Li, Chengjiang
Lu, Juming
Yang, Jinkui
Li, Wenhui
Zeng, Jiaoe
Chan, Julianna
Hsieh, An-Tsz
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1150-P
引用
收藏
页码:A299 / A299
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of alogliptin in subjects with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 study in mainland China, Taiwan and Hong Kong
    Ji, Q.
    Han, P.
    Li, C.
    Lu, J.
    Yang, J.
    Li, W.
    Zeng, J.
    Hsieh, A. -T.
    Chan, J.
    Pan, C.
    DIABETOLOGIA, 2013, 56 : S365 - S365
  • [2] Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong
    Pan, Changyu
    Han, Ping
    Ji, Qiuhe
    Li, Chengjiang
    Lu, Juming
    Yang, Jinkui
    Li, Wenhui
    Zeng, Jiaoe
    Hsieh, An-Tsz
    Chan, Juliana
    JOURNAL OF DIABETES, 2017, 9 (04) : 386 - 395
  • [3] Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
    Gupta, Pawan Kumar
    Maheshwari, Sunil
    Cherian, Joe Joseph
    Goni, Vijay
    Sharma, Arun Kumar
    Tripathy, Sujith Kumar
    Talari, Keerthi
    Pandey, Vivek
    Sancheti, Parag Kantilal
    Singh, Saurabh
    Verma, Nikhil N.
    Kumar, Uday
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2254 - 2266
  • [4] Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial
    Ji, Linong
    Lu, Jinmiao
    Gao, Leili
    Ying, Changjiang
    Sun, Jiao
    Han, Jie
    Zhao, Wenhua
    Gao, Yunming
    Wang, Kun
    Zheng, Xin
    Xie, Daosheng
    Ding, Juping
    Zhao, Jiahong
    Yu, Qiang
    Wang, Tong
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3671 - 3681
  • [5] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, H. K.
    Lee, S. H.
    Min, K. W.
    Park, S. W.
    Chung, C. H.
    Park, K. S.
    Choi, S. H.
    Song, K. -H.
    Kim, D. -M.
    Lee, M. -K.
    Sung, Y. A.
    Baik, S. H.
    Kim, I. J.
    Cha, B. -S.
    Park, J. H.
    Ahn, Y. B.
    Lee, I. -K.
    Yoo, S. -J.
    Kim, J. T.
    Park, I. B.
    Park, T. S.
    Yoon, K. -H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150
  • [6] Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study
    H Toplak
    A Hamann
    R Moore
    E Masson
    M Gorska
    F Vercruysse
    X Sun
    M Fitchet
    International Journal of Obesity, 2007, 31 : 138 - 146
  • [7] Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study
    Toplak, H.
    Hamann, A.
    Moore, R.
    Masson, E.
    Gorska, M.
    Vercruysse, F.
    Sun, X.
    Fitchet, M.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (01) : 138 - 146
  • [8] Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-blind, Multicenter, Placebo-Controlled Phase 3 Study
    Mueller, Daniel S.
    Prinz, Valentina
    Adelglass, Jeffrey
    Cox, Sue Ellen
    Gold, Michael H.
    Kaufman-Janette, Joely
    Nestor, Mark S.
    Taylor, Susan
    Frank, Konstantin
    AESTHETIC SURGERY JOURNAL, 2022, 42 (06) : 677 - 688
  • [9] Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study
    Seino, Yutaka
    Sasaki, Takashi
    Fukatsu, Atsushi
    Ubukata, Michito
    Sakai, Soichi
    Samukawa, Yoshishige
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (07) : 1245 - 1255
  • [10] A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Samidorphan in Adults With Alcohol Dependence
    O'Malley, Stephanie
    Todtenkopf, Mark
    Ehrich, Elliot
    Silverman, Bernard L.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S276 - S276